Literature DB >> 19240992

[Once-yearly administration of zoledronic acid to treat post-menopausal osteoporosis].

S Seitz1, M Schieker, W Mutschler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19240992     DOI： 10.1007/s00113-009-1587-0

Source DB:  PubMed          Journal:  Unfallchirurg        ISSN： 0177-5537            Impact factor:   1.000


× No keyword cloud information.
  3 in total

1.  Persistence with weekly alendronate therapy among postmenopausal women.

Authors:  J C Lo; A R Pressman; M A Omar; B Ettinger
Journal:  Osteoporos Int       Date:  2006-04-12       Impact factor: 4.507

2.  Intravenous zoledronic acid in postmenopausal women with low bone mineral density.

Authors:  Ian R Reid; Jacques P Brown; Peter Burckhardt; Zebulun Horowitz; Peter Richardson; Ulrich Trechsel; Albert Widmer; Jean-Pierre Devogelaer; Jean-Marc Kaufman; Philippe Jaeger; Jean-Jacques Body; Maria Luisa Brandi; Johann Broell; Raffaele Di Micco; Andrea Riccardo Genazzani; Dieter Felsenberg; Joachim Happ; Michael J Hooper; Jochen Ittner; Georg Leb; Hans Mallmin; Timothy Murray; Sergio Ortolani; Alessandro Rubinacci; Maria Saaf; Goran Samsioe; Leon Verbruggen; Pierre J Meunier
Journal:  N Engl J Med       Date:  2002-02-28       Impact factor: 91.245

3.  Zoledronic acid and clinical fractures and mortality after hip fracture.

Authors:  Kenneth W Lyles; Cathleen S Colón-Emeric; Jay S Magaziner; Jonathan D Adachi; Carl F Pieper; Carlos Mautalen; Lars Hyldstrup; Chris Recknor; Lars Nordsletten; Kathy A Moore; Catherine Lavecchia; Jie Zhang; Peter Mesenbrink; Patricia K Hodgson; Ken Abrams; John J Orloff; Zebulun Horowitz; Erik Fink Eriksen; Steven Boonen
Journal:  N Engl J Med       Date:  2007-09-17       Impact factor: 91.245
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.